Found: 251
Select item for more details and to access through your institution.
First person profile: Dr Carl June: Dr June recently participated on a panel with the FDA to discuss the next steps needed to expand CAR T‐cell therapy into areas other than blood cancers.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 14, p. 2406, doi. 10.1002/cncr.35420
- By:
- Publication type:
- Article
New standard of care for bladder cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 14, p. 2407, doi. 10.1002/cncr.35421
- By:
- Publication type:
- Article
Novel hormone is safe and effective in men receiving radiotherapy for prostate cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 14, p. 2408, doi. 10.1002/cncr.35422
- By:
- Publication type:
- Article
AACR 2024 presents advancements in pancreatic and gastric cancers: Promising evidence has been found for the therapeutic potential of a neoantigen‐based cancer vaccine used in the adjuvant setting.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 13, p. 2244, doi. 10.1002/cncr.35371
- By:
- Publication type:
- Article
Significant overall survival benefit with dostarlimab plus chemotherapy in advanced endometrial cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 13, p. 2245, doi. 10.1002/cncr.35372
- By:
- Publication type:
- Article
Favorable overall survival trend with pembrolizumab plus chemotherapy for endometrial cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 13, p. 2246, doi. 10.1002/cncr.35373
- By:
- Publication type:
- Article
First person profile: Everett Vokes, MD: Pioneer of the combination of radiation and chemotherapy as the first line of treatment for head and neck cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 12, p. 2082, doi. 10.1002/cncr.35358
- By:
- Publication type:
- Article
Addressing heart health in survivors of childhood cancers.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 12, p. 2083, doi. 10.1002/cncr.35359
- By:
- Publication type:
- Article
Simple blood test predicts patients most likely to have poor CAR T‐cell outcomes.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 12, p. 2084, doi. 10.1002/cncr.35360
- By:
- Publication type:
- Article
Rethinking dose optimization in drug development: A goal of Project Optimus is to educate and collaborate with drug developers to select doses of drugs under investigation with a focus on maximizing efficacy, safety, and tolerability.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 11, p. 1902, doi. 10.1002/cncr.35345
- By:
- Publication type:
- Article
FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 11, p. 1903, doi. 10.1002/cncr.35346
- By:
- Publication type:
- Article
Cancer Statistics 2024: Deaths drop, incidences increase, prevention needed.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 11, p. 1904, doi. 10.1002/cncr.35347
- By:
- Publication type:
- Article
First person profile: Barbara Burtness, MD: For more than 20 years, she has applied advances in molecular biology to better treat patients with head and neck cancers.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 10, p. 1724, doi. 10.1002/cncr.35311
- By:
- Publication type:
- Article
Improving access to care and outcomes via Medicaid expansion.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 10, p. 1725, doi. 10.1002/cncr.35312
- By:
- Publication type:
- Article
Cancer center matters for appropriate use of immunotherapy at end of life.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 10, p. 1726, doi. 10.1002/cncr.35313
- By:
- Publication type:
- Article
Dynamic risk prediction model for multiple myeloma: Through deep learning, the model is able to adapt to future data, such as emerging treatment modalities and combinations.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1546, doi. 10.1002/cncr.35294
- By:
- Publication type:
- Article
Global phase 3 results show that bevacizumab with immunotherapy has activity in liver cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1547, doi. 10.1002/cncr.35295
- By:
- Publication type:
- Article
New standard of care for multiple myeloma?
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1548, doi. 10.1002/cncr.35296
- By:
- Publication type:
- Article
First person profile: Mona Fouad, MD, MPH: Dr Fouad is credited for initiating and implementing programs throughout Alabama aimed at educating people about good health practices, the benefits of screening for early detection, and health literacy.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1190, doi. 10.1002/cncr.35271
- By:
- Publication type:
- Article
Golidocitinib favorable for relapsed/refractory T‐cell lymphoma.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1191, doi. 10.1002/cncr.35272
- By:
- Publication type:
- Article
Promising new treatment approaches for locally advanced cervical cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1192, doi. 10.1002/cncr.35273
- By:
- Publication type:
- Article
2023 American Society of Hematology meeting roundup: Results from several studies show improvement based on adding a new element to standard therapies.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 7, p. 1012, doi. 10.1002/cncr.35253
- By:
- Publication type:
- Article
Cardiotoxicity of breast cancer drugs requires additional monitoring.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 7, p. 1013, doi. 10.1002/cncr.35254
- By:
- Publication type:
- Article
Routine estradiol testing recommended for women at high risk of breast cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 7, p. 1014, doi. 10.1002/cncr.35255
- By:
- Publication type:
- Article
First person profile: Betty Ferrell, PhD, RN: Dr Ferrell has built her career on the belief that palliative care should be offered from the time of cancer diagnosis rather than just as end‐of‐life care.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 6, p. 834, doi. 10.1002/cncr.35237
- By:
- Publication type:
- Article
FDA approves capivasertib with fulvestrant for breast cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 6, p. 835, doi. 10.1002/cncr.35238
- By:
- Publication type:
- Article
FDA authorizes blood test for risk assessment of hereditary cancers.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 6, p. 836, doi. 10.1002/cncr.35239
- By:
- Publication type:
- Article
Updated American Cancer Society lung cancer screening guidelines: The new guidelines offer expanded criteria recommended for lung cancer screening based on age, smoking status, and smoking history.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 656, doi. 10.1002/cncr.35223
- By:
- Publication type:
- Article
Continuous expansion of telehealth in cancer care.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 657, doi. 10.1002/cncr.35224
- By:
- Publication type:
- Article
Helping patients with cancer to understand secondary findings on genetic tests.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 658, doi. 10.1002/cncr.35225
- By:
- Publication type:
- Article
First person profile: Michelle M. Le Beau, PhD: Dr Le Beau's fascination with cancer cytogenetics has contributed to vast improvements in the treatment of certain cancers based on genetic subgroups.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 4, p. 494, doi. 10.1002/cncr.35194
- By:
- Publication type:
- Article
Phase 3 AEGEAN trial results show the benefit of perioperative immunotherapy‐based treatment for NSCLC.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 4, p. 495, doi. 10.1002/cncr.35193
- By:
- Publication type:
- Article
Improved progression‐free survival, increased toxicities seen with amivantamab for EGFR‐mutant NSCLC.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 4, p. 496, doi. 10.1002/cncr.35195
- By:
- Publication type:
- Article
Improving follow‐up of abnormal cancer screening results: Basic interventions and reminders in the electronic health record can help increase the benefits of timely follow‐up for patients.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 3, p. 332, doi. 10.1002/cncr.35191
- By:
- Publication type:
- Article
Major advancements in first‐line treatments for advanced urothelial cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 3, p. 333, doi. 10.1002/cncr.35192
- By:
- Publication type:
- Article
First person profile: Patrick J. Loehrer, MD: Dr Loehrer's lifelong passion for bringing high‐quality oncology care to underresourced communities has taken on global dimensions.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 2, p. 170, doi. 10.1002/cncr.35160
- By:
- Publication type:
- Article
Oral health linked to survival in head and neck cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 2, p. 171, doi. 10.1002/cncr.35161
- By:
- Publication type:
- Article
Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 2, p. 172, doi. 10.1002/cncr.35162
- By:
- Publication type:
- Article
Discrepancy in accelerated approvals for cancer drugs in the United States and Europe: The FDA and the EMA have different lists of drugs for which accelerated approvals have been withdrawn, and patient confusion can be a result.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 1, p. 8, doi. 10.1002/cncr.35138
- By:
- Publication type:
- Article
First person profile: Patricia M. LoRusso, DO: This researcher and clinician has conducted work in early‐phase trials that has led to the approval of several anticancer agents, all while keeping her focus on the patients she says make these trials possible
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3840, doi. 10.1002/cncr.35121
- By:
- Publication type:
- Article
Are multicancer early detection screening tests a hoped‐for breakthrough?: Although these tests have the potential to detect multiple cancer types earlier, research is underway to determine if their benefits outweigh their drawbacks.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3678, doi. 10.1002/cncr.35086
- By:
- Publication type:
- Article
Thymus removal in adults increases cancer risk and mortality.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3679, doi. 10.1002/cncr.35087
- By:
- Publication type:
- Article
Targeting metabolic abnormality for advanced prostate cancer: The prodrug Platin‐L effectively targets the metabolic abnormality needed to make this cancer sensitive to cisplatin.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3516, doi. 10.1002/cncr.35080
- By:
- Publication type:
- Article
Expanding rural‐area oncology service access through 340B Drug Pricing Program participation.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3517, doi. 10.1002/cncr.35081
- By:
- Publication type:
- Article
Systemic therapies at the end of life vary by patient and practice: Whether or not patients with cancer at the end of life received systemic therapies, including immunotherapies, depended partly on their race, insurance type, and the practice at which they were treated, but are decisions based on these factors in the patients' best interests?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3354, doi. 10.1002/cncr.35053
- By:
- Publication type:
- Article
Staging laparoscopy before therapy for pancreatic cancer is valuable.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3355, doi. 10.1002/cncr.35054
- By:
- Publication type:
- Article
New potential therapy for relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3356, doi. 10.1002/cncr.35055
- By:
- Publication type:
- Article
First person profile: Jedd Wolchok, MD: Advances in treating metastatic melanoma can, in part, be charted by the career of Dr Wolchok, who was on the front lines of investigating immunotherapy science and developed the first immunologic agents to treat melanoma
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 20, p. 3190, doi. 10.1002/cncr.35016
- By:
- Publication type:
- Article
Certain cancer types show global variation in mortality rates.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 20, p. 3191, doi. 10.1002/cncr.35017
- By:
- Publication type:
- Article
Genomics likely are not the main driver in advanced prostate cancer overall survival rate disparities.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 20, p. 3192, doi. 10.1002/cncr.35018
- By:
- Publication type:
- Article